Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sodium Picosulphate 10 mg Tablet
Therapeutic Category
Gastroenterology, Laxatives
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹90/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Sodium Picosulphate 10 mg Tablet is a stimulant laxative used to treat constipation and prepare the bowel before medical procedures such as colonoscopy. It works by stimulating the nerves in the intestinal wall, which increases bowel movements and helps facilitate smoother stool passage. The action is typically seen within 6–12 hours after administration, making it suitable for short-term relief of occasional constipation.
Sodium Picosulphate is generally well tolerated. Some users may experience abdominal cramps, bloating, or diarrhea. Prolonged or excessive use may lead to fluid and electrolyte imbalance. Rare allergic reactions such as skin rash or swelling may occur and should be reported immediately.
This tablet is indicated for the treatment of occasional or chronic constipation. It is also commonly prescribed as part of bowel cleansing regimens prior to diagnostic procedures involving the colon, such as colonoscopy or radiologic exams.
Use this medicine under medical advice, especially in cases of prolonged constipation. It is not intended for long-term use without supervision. Avoid in patients with intestinal obstruction, acute inflammatory bowel conditions, or severe dehydration. Keep out of reach of children.
Store in a cool and dry place, below 25°C. Protect from moisture and direct sunlight. Keep the tablet in its original packaging until use.
Composition : Lactulose 15 ml contains lactulose concentrate 66.7% in 6 gm Syrup
Composition : Ayurvedic Constipation Syrup
Composition : Aceclofenac (200mg) + Rabeprazole (20mg) Capsule
Composition : Acotiamide (100mg) Tablet
Composition : Acotiamide (300mg) Tablet
Composition : Magaldrate I.P. 400mg + Simethicone I.P. 20mg (Mango & Mint Flavour)
Composition : Magaldrate I.P. 480mg + Simethicone I.P. 20mg + Oxetacaine B.P. 10mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sodium picosulfate Tablets have strong demand in the gastrointestinal and constipation management segment, making them a fast-moving product for pharma distributors, wholesalers, and franchise partners. It is widely used for acute and chronic constipation, irregular bowel movements, and bowel evacuation preparation, ensuring consistent prescription and OTC demand.
Medical distributors and agencies benefit from the very high prevalence of constipation due to modern lifestyle, diet, and medication side effects. Strong stimulant laxative action for effective bowel movement Used in chronic constipation and occasional constipation cases Helps in bowel evacuation prior to diagnostic procedures (as prescribed) Widely prescribed by general physicians and gastroenterologists Suitable for short-term and controlled constipation therapy Strong demand in hospital and retail pharmacy segments This makes it a fast-moving gastrointestinal laxative product with consistent repeat demand.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sodium Picosulphate 10 mg Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from steady constipation treatment demand, strong OTC movement, repeat usage in chronic cases, and stable year-round turnover in the gastro segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete gastrointestinal laxative product portfolio access to build a strong presence in the digestive health market.